Open Journal of Ophthalmology
Vol.2 No.3(2012), Paper ID 21891, 4
pages
DOI:10.4236/ojoph.2012.23020
Three Consecutive Monthly Intravitreal Ranibizumab for Choroidal Neovascularization in Central Serous Choriorethinopathy: A Case Report
Kazim Erol, Esin Sogutlu Sari, Arif Koytak, A Karaçor, D. T. Çoban, M. Bulut
Antalya Training and Research Hospital, Ophthalmology Department, Antalya, Turkey
Kartal Training and Research Hospital, Ophthalmology Department, Istanbul, Turkey
Bezmialem Vak?f University, Ophthalmology Department, Istanbul, Turkey
Antalya Training and Research Hospital, Ophthalmology Department, Antalya, Turkey
Antalya Training and Research Hospital, Ophthalmology Department, Antalya, Turkey
Antalya Training and Research Hospital, Ophthalmology Department, Antalya, Turkey
Copyright © 2012 Kazim Erol, Esin Sogutlu Sari, Arif Koytak, A Karaçor, D. T. Çoban, M. Bulut et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
K. Erol, E. Sogutlu Sari, A. Koytak, A. Karaçor, D. T. Çoban and M. Bulut, "Three Consecutive Monthly Intravitreal Ranibizumab for Choroidal Neovascularization in Central Serous Choriorethinopathy: A Case Report,"
Open Journal of Ophthalmology, Vol. 2 No. 3, 2012, pp. 93-96. doi:
10.4236/ojoph.2012.23020.